CDKN2A and Ewing sarcoma: The frequent normal functioning of the p53 signaling pathway in ESFTs is also demonstrated by the observation that almost all Ewing Sarcoma cell lines have acquired either TP53 mutations or CDKN2A deletions, suggesting selective pressure for these genetic alterations to permit in vitro growth [67].